Nothing Special   »   [go: up one dir, main page]

NO20031999D0 - Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod - Google Patents

Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod

Info

Publication number
NO20031999D0
NO20031999D0 NO20031999A NO20031999A NO20031999D0 NO 20031999 D0 NO20031999 D0 NO 20031999D0 NO 20031999 A NO20031999 A NO 20031999A NO 20031999 A NO20031999 A NO 20031999A NO 20031999 D0 NO20031999 D0 NO 20031999D0
Authority
NO
Norway
Prior art keywords
stem cells
well
cord blood
somatic stem
restricted
Prior art date
Application number
NO20031999A
Other languages
English (en)
Other versions
NO20031999L (no
Inventor
Peter Wernet
Original Assignee
Kourion Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kourion Therapeutics Gmbh filed Critical Kourion Therapeutics Gmbh
Publication of NO20031999D0 publication Critical patent/NO20031999D0/no
Publication of NO20031999L publication Critical patent/NO20031999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
NO20031999A 2000-11-03 2003-05-02 Ikke-begrensede somatiske stamceller avledet fra humant navlestrengblod NO20031999L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24516800P 2000-11-03 2000-11-03
PCT/EP2001/012768 WO2002036751A2 (en) 2000-11-03 2001-11-03 Human cord blood derived unrestricted somatic stem cells (ussc)

Publications (2)

Publication Number Publication Date
NO20031999D0 true NO20031999D0 (no) 2003-05-02
NO20031999L NO20031999L (no) 2003-07-02

Family

ID=22925565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031999A NO20031999L (no) 2000-11-03 2003-05-02 Ikke-begrensede somatiske stamceller avledet fra humant navlestrengblod

Country Status (25)

Country Link
US (3) US7560280B2 (no)
EP (1) EP1404815B1 (no)
JP (2) JP4799804B2 (no)
CN (1) CN100480375C (no)
AT (1) ATE340255T1 (no)
AU (2) AU2002229533B2 (no)
BG (1) BG107770A (no)
CA (1) CA2426987C (no)
CY (1) CY1106287T1 (no)
CZ (1) CZ20031165A3 (no)
DE (1) DE60123293T2 (no)
DK (1) DK1404815T3 (no)
EA (1) EA008619B1 (no)
EE (1) EE200300205A (no)
ES (1) ES2272563T3 (no)
HK (1) HK1071771A1 (no)
HU (1) HUP0301600A3 (no)
IL (2) IL155608A0 (no)
MX (1) MXPA03003844A (no)
NO (1) NO20031999L (no)
PL (1) PL362293A1 (no)
PT (1) PT1404815E (no)
SK (1) SK5242003A3 (no)
UA (1) UA81390C2 (no)
WO (1) WO2002036751A2 (no)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100529B2 (en) * 1998-07-30 2010-08-25 The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health Thymosin beta 4 promotes wound repair
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
WO2005056026A1 (en) 2003-12-04 2005-06-23 Regents Of The University Of Minnesota Compositions and methods for the treatment of lysosomal storage disorders
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7927587B2 (en) * 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
US8075881B2 (en) * 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
EP1226233B1 (en) * 1999-08-05 2011-06-29 ABT Holding Company Multipotent adult stem cells and methods for isolation
CA2438501C (en) * 2001-02-14 2014-09-16 Leo T. Furcht Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
CN1547480A (zh) * 2001-08-29 2004-11-17 雷根内克斯生物制药有限公司 用胸腺素β4、类似物、同型物和其他衍生物在心肌事件发生前、过程中或刚发生后治疗或预防炎症、损伤和其他改变的方法
DE10144326B4 (de) * 2001-09-10 2005-09-22 Siemens Ag Verfahren und System zur Überwachung eines Reifenluftdrucks
DE10158680B4 (de) * 2001-11-30 2004-04-08 Universitätsklinikum Hamburg-Eppendorf Verfahren zur ex vivo-Expansion und -Differenzierung von multipotenten Stammzellen
CA2473749C (en) * 2002-01-23 2012-05-22 University Of Utah Research Foundation Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof
JP2005517441A (ja) * 2002-02-19 2005-06-16 メディポスト・カンパニー・リミテッド 臍帯血由来の間葉幹細胞・前駆細胞の分離培養方法及び間葉組織への分化誘導方法
JP2006509770A (ja) 2002-11-26 2006-03-23 アンソロジェネシス コーポレーション 細胞治療学、細胞治療単位、およびそれらを利用した治療法
WO2004050859A2 (en) 2002-11-27 2004-06-17 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
WO2004052177A2 (en) * 2002-12-05 2004-06-24 Case Western Reserve University Cell-based therapies for ischemia
JP3762975B2 (ja) * 2003-03-18 2006-04-05 学校法人慶應義塾 単球由来多能性細胞ｍｏｍｃ
US20040203142A1 (en) * 2003-04-14 2004-10-14 Reliance Life Sciences Pvt. Ltd. Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation thereof for therapeutic purposes
JP4950661B2 (ja) 2003-06-27 2012-06-13 エチコン、インコーポレイテッド 分娩後由来細胞類を使用する、神経組織の再生および修復
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
AU2003304250A1 (en) 2003-06-27 2005-01-13 Universite Laval Method of isolating cells from umbilical cord
WO2005032251A1 (en) * 2003-10-09 2005-04-14 I.M.T. Interface Multigrad Technology Ltd. Method for freezing, thawing and transplantation of viable cartilage
GB0329449D0 (en) * 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
JP2007520462A (ja) * 2003-12-19 2007-07-26 バイアセル インコーポレーティッド ヒト臍帯血由来多能性細胞の疾患の処置のための使用方法
EP1544290A1 (en) * 2003-12-19 2005-06-22 Yu-Show Fu A cell system for generating somatic cells
JP4777908B2 (ja) * 2004-02-02 2011-09-21 コア・ダイナミクス・リミテッド 生物学的材料ならびに生物学的材料の保存のための方法および溶液
WO2005073652A2 (en) * 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Apparatus, system and method for lyophilization
EP1718735A1 (en) * 2004-02-11 2006-11-08 Aldagen, Inc. Stem cell populations and methods of use
EP1747265B1 (en) * 2004-04-23 2011-04-20 BioE LLC Multi-lineage progenitor cells
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
JP2007536935A (ja) 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 間葉幹細胞の無血清増殖のための細胞培養環境
EP1753472B1 (en) * 2004-06-07 2010-03-17 Core Dynamics Ltd Method for sterilization of biological preparations
EP1778007A1 (en) * 2004-08-12 2007-05-02 I.M.T. Interface Multigrad Technology Ltd. Method and apparatus for freezing or thawing of a biological material
US9056093B2 (en) 2005-01-07 2015-06-16 Wake Forest University Health Sciences Regeneration of pancreatic islets by amniotic fluid stem cell therapy
EP2428563A1 (en) * 2005-02-10 2012-03-14 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
EP1850661A2 (en) * 2005-02-22 2007-11-07 Interface Multigrad Technology (IMT) Ltd. Preserved viable cartilage, method for its preservation, and system and devices used therefor
CN101575590B (zh) * 2005-02-28 2012-05-23 中国医学科学院血液学研究所泰达生命科学技术研究中心 人脐带间充质干细胞的制备方法
EP1874922A4 (en) * 2005-04-19 2009-10-28 Univ Johns Hopkins METHOD USING STROMA CELLS FROM UMBILICAL CORD BLOOD TO DEVELOP AND GRAFT NUCLEAR CELLS DERIVED FROM UMBILICAL CORD BLOOD
WO2006121454A2 (en) * 2005-05-05 2006-11-16 Regents Of The University Of Minnesota Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
CN101218341A (zh) * 2005-05-05 2008-07-09 明尼苏达大学董事会 Nk细胞抑制作用用于促进定植的mhc-i阴性细胞持续存在的用途
EP2662439A1 (en) * 2005-05-27 2013-11-13 Viacord, LLC Treatment of ischemia using stem cells
US20080194024A1 (en) * 2005-07-29 2008-08-14 Mays Robert W Culture of Non-Embryonic Cells at High Cell Density
EP1909565A2 (en) 2005-08-03 2008-04-16 Interface Multigrad Technology (IMT) Ltd. Somatic cells for use in cell therapy
DE602005017812D1 (de) * 2005-08-26 2009-12-31 Seoul Nat Univ Ind Foundation Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit
EP1941032A2 (en) 2005-10-14 2008-07-09 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
ES2642844T3 (es) 2005-12-16 2017-11-20 DePuy Synthes Products, Inc. Composiciones y métodos para inhibir una respuesta inmune adversa en el trasplante de histocompatibilidad que no coinciden
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
PL2471903T3 (pl) 2005-12-29 2018-09-28 Anthrogenesis Corporation Populacje komórek macierzystych łożyska
WO2007121443A2 (en) * 2006-04-17 2007-10-25 Bioe, Inc. Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
ES2524443T3 (es) * 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores
WO2008085229A2 (en) * 2006-11-15 2008-07-17 Arteriocyte Inc. Cell-based therapies for treating liver disease
EP2087101A2 (en) * 2006-11-24 2009-08-12 Regents of the University of Minnesota Endodermal progenitor cells
AU2007326171B2 (en) 2006-11-30 2012-11-15 Medipost Co., Ltd. Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
US20090029463A1 (en) * 2007-07-25 2009-01-29 Bioe, Inc. Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
MX2010004914A (es) * 2007-10-31 2010-08-18 Cryo Cell Int Metodos para cocultivar celulas derivadas de sangre de cordon umbilical con celulas madre menstruales.
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
CN101978047A (zh) 2008-01-18 2011-02-16 明尼苏达大学董事会 干细胞聚集体及制备和使用方法
US20090202978A1 (en) * 2008-02-13 2009-08-13 Ginadi Shaham Method and apparatus for freezing of a biological material
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
CN101543644B (zh) * 2008-03-27 2012-07-25 中国人民解放军总医院 无支架工程软骨组织的构建方法及其产品
CA2724839A1 (en) * 2008-05-21 2009-11-26 Bioe Llc Differentiation of multi-lineage progenitor cells to pancreatic cells
JP2012500792A (ja) 2008-08-22 2012-01-12 アンスロジェネシス コーポレーション 胎盤細胞集団による骨欠損の治療のための方法および組成物
EP4032552B1 (en) 2008-08-26 2023-10-04 City of Hope Method and compositions for enhanced anti-tumor effector functioning of t cells
GB0818725D0 (en) 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
EP2182055A1 (en) 2008-10-14 2010-05-05 Heinrich-Heine-Universität Düsseldorf Human cord blood derived unrestricted somatic stem cells (USSC)
WO2010049752A1 (en) 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
KR20100054711A (ko) 2008-11-14 2010-05-25 메디포스트(주) 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
AU2010276264B2 (en) 2009-07-21 2013-09-19 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
EP2456853B1 (en) 2009-07-21 2020-10-28 ABT Holding Company Use of stem cells to reduce leukocyte extravasation
US9081008B2 (en) 2009-12-04 2015-07-14 James Sherley Detecting and counting tissue—specific stem cells and uses thereof
US8759098B2 (en) 2009-12-04 2014-06-24 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
SG10201914001QA (en) 2010-02-25 2020-03-30 Abt Holding Co Modulation of macrophage activation
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
WO2011143415A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy
US9090878B2 (en) 2010-06-17 2015-07-28 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
WO2012027358A1 (en) 2010-08-23 2012-03-01 President And Fellows Of Harvard College Optogenetic probes for measuring membrane potential
CA2809245C (en) 2010-08-24 2020-07-14 Regents Of The University Of Minnesota Non-static suspension culture of cell aggregates
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
US20120258439A1 (en) * 2011-04-11 2012-10-11 Ali Bin M Abdullah Jaffar Protein-Free Culture Media Products
CN102776150A (zh) * 2011-05-13 2012-11-14 上海交通大学医学院附属第九人民医院 一种诱导脐带间充质干细胞分化为内皮细胞的方法
US9040035B2 (en) 2011-06-01 2015-05-26 Anthrogenesis Corporation Treatment of pain using placental stem cells
HUE047474T2 (hu) 2011-06-06 2020-04-28 ReGenesys BVBA Õssejtek expanziója üreges rostbioreaktorokban
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
SG11201508403XA (en) 2013-04-12 2015-11-27 Saverio Lafrancesca Improving organs for transplantation
EP2992088B1 (en) 2013-04-30 2019-08-21 Katholieke Universiteit Leuven Cell therapy for myelodysplastic syndromes
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
EP2952578A1 (de) 2014-06-03 2015-12-09 Peter Wernet Epigenetische Reprogrammierung von fötalen Stammzellen
JP6657195B2 (ja) 2014-09-19 2020-03-04 シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ Ｌ１３Ｒα２を標的とする共刺激性キメラ抗原レセプターＴ細胞
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
AU2016387339B2 (en) 2016-01-21 2022-11-17 Abt Holding Company Stem cells for wound healing
CN106377547B (zh) * 2016-09-30 2019-05-31 孔五一 脐带血再生粒子的提取方法及其用途
CN113637633B (zh) * 2021-08-16 2023-11-03 浙江大学 一种促进间充质干细胞向成骨细胞分化的方法
CA3232099A1 (en) 2021-09-23 2023-03-30 Adam Ezra Cohen Genetically encoded voltage indicators and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3639949A1 (de) 1986-11-22 1988-06-09 Diagen Inst Molekularbio Verfahren zur trennung von langkettigen nukleinsaeuren
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5672346A (en) * 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
WO1997039104A1 (en) * 1996-04-17 1997-10-23 Osiris Therapeutics, Inc. Cryopreservation and extensive subculturing of human mesenchymal stem cells
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
JPH10295369A (ja) 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
JPH10306027A (ja) 1997-03-07 1998-11-17 Otsuka Pharmaceut Co Ltd 免疫寛容誘導剤
US6387369B1 (en) * 1997-07-14 2002-05-14 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
DE19833476B4 (de) 1998-07-24 2005-08-25 Huss, Ralf, Dr. Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie
CA2371017A1 (en) 1999-04-27 2000-11-02 Layton Bioscience, Inc. Cell therapy for chronic stroke
US20020142457A1 (en) * 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
JP2005517441A (ja) * 2002-02-19 2005-06-16 メディポスト・カンパニー・リミテッド 臍帯血由来の間葉幹細胞・前駆細胞の分離培養方法及び間葉組織への分化誘導方法
US20040197310A1 (en) * 2003-02-12 2004-10-07 Sanberg Paul R. Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction

Also Published As

Publication number Publication date
EA008619B1 (ru) 2007-06-29
CN1553951A (zh) 2004-12-08
DE60123293D1 (de) 2006-11-02
NO20031999L (no) 2003-07-02
PT1404815E (pt) 2006-12-29
EE200300205A (xx) 2003-08-15
CZ20031165A3 (cs) 2003-10-15
JP4799804B2 (ja) 2011-10-26
US7560280B2 (en) 2009-07-14
UA81390C2 (en) 2008-01-10
JP2008179642A (ja) 2008-08-07
BG107770A (bg) 2004-02-27
HK1071771A1 (en) 2005-07-29
CA2426987C (en) 2013-06-11
CA2426987A1 (en) 2002-05-10
JP4805960B2 (ja) 2011-11-02
WO2002036751A2 (en) 2002-05-10
EP1404815B1 (en) 2006-09-20
WO2002036751A3 (en) 2004-01-08
JP2004521617A (ja) 2004-07-22
US20050142118A1 (en) 2005-06-30
EP1404815A2 (en) 2004-04-07
PL362293A1 (en) 2004-10-18
AU2002229533B2 (en) 2007-07-26
HUP0301600A3 (en) 2005-12-28
ATE340255T1 (de) 2006-10-15
AU2953302A (en) 2002-05-15
IL155608A0 (en) 2003-11-23
IL155608A (en) 2009-08-03
CY1106287T1 (el) 2011-10-12
EA200300536A1 (ru) 2003-12-25
MXPA03003844A (es) 2004-10-15
US7556801B2 (en) 2009-07-07
DE60123293T2 (de) 2007-05-10
HUP0301600A2 (hu) 2003-10-28
DK1404815T3 (da) 2007-01-08
SK5242003A3 (en) 2003-11-04
ES2272563T3 (es) 2007-05-01
US20090238803A1 (en) 2009-09-24
CN100480375C (zh) 2009-04-22
US20020164794A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
NO20031999D0 (no) Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod
TW200712208A (en) Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
Goncharova et al. Application of autologous adipose-derived stem cells for thin endometrium treatment in patients with failed ART programs
US20100172951A1 (en) Enhanced Medical Implant
DK1405906T3 (da) Schwann-celler stammende fra stromale knoglemarvsceller
Singh et al. Bone marrow derived stem cells in trauma and orthopaedics: a review of the current trend
Imran et al. Regenerative medicine therapy in Malaysia: an update
Qu et al. Biological characteristics and effect of human umbilical cord mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on bone regeneration in rats
Yaneselli et al. Allogeneic stem cell transplantation for bone regeneration of a nonunion defect in a canine
CN105999416A (zh) 用于整形充填的自体脂肪与脐带间充质干细胞组合物
Ramzgouyan et al. Differentiation of human endometrial stem cells into germ cell–Like cell in fibrin scaffold
Sheikhani-Shahin et al. The healing effect of bone marrow-derived stem cells and aquatic activity in Achilles tendon injury
McCall et al. Journal of Stem Cell Research
Zou Tissue Engineering for Degenerative Intervertebral Discs
CN106563160A (zh) 制备组织工程骨的方法
Hemalatha et al. Dental stem cells origin, banking, engineering and applications
Peng et al. Influence of various volume fractions of platelet-rich plasma on the proliferation of rat hair follicle stem cells
Pushpalatha et al. Dental pulp stem cells scope in dentistry; a review
SHEIKHANI-SHAHIN Copyright© 2019 H. SHEIKHANI-SHAHIN, D. MEHRABANI, MJ ASHRAF, H. RAJABI, M. NOROUZIAN, F. RAHMANIFAR, S. DEHGHANI NAZHVANI, S. ZARE
Sielker et al. Isolation and cultivation of human mandibular osteoblasts
Mohammadi Begum ROLE OF STEM CELLS IN ORTHODONTICS-A REVIEW
Fraticelli Stem Cell Therapy Applications: The Challenge of Regenerative Medicine
Veleska-Stevkovska et al. Potential clinical applications of dental stem cells
Larson et al. Journal of Cell Science & Therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application